EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events

Maria Nektaria Magkoulia, Despoina Pantazi iD

Phytotherapy Research · 2026-11 · 40 (11) · 6130-6153

DOI: 10.1002/ptr.70415 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 29.06.2026. Verfasst von Maria Nektaria Magkoulia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Biological Products, Thrombosis, Fibrinolytic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bioactive compounds derived from natural products (NPs) continue to attract considerable scientific interest due to their wide range of beneficial biological activities. This review examines the role of these compounds in the prevention and management of cardiovascular disease (CVD), with particular emphasis on their involvement in thrombotic processes. Specifically, this review addresses whether bioactive NPs can serve as complementary therapeutic agents in preventing and modulating thrombotic events associated with CVD. Special attention is given to natural food sources with well‐documented antithrombotic properties, as well as to current methodologies used for the processing, extraction, and isolation of their biologically active constituents. Furthermore, emerging evidence regarding the impact of chronic dietary intake of bioactive compounds on the pharmacokinetics and therapeutic efficacy of antithrombotic agents is discussed, including potential interactions with commonly prescribed anticoagulant drugs. The contribution of nutritional epigenetics to personalized strategies for CVD prevention and treatment—especially through gene–diet interactions—is also explored. In addition, the growing role of artificial intelligence in accelerating the discovery and optimization of novel natural antithrombotic agents is highlighted within the context of recent technological advances. Overall, this review underscores the potential of NPs as integral components of innovative and complementary strategies for CVD management, primarily through their pronounced antiplatelet and antithrombotic activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesBiological ProductsThrombosisFibrinolytic AgentsHumansAnimalsPlatelet Aggregation InhibitorsAnticoagulants

Stichwörter der Autor:innen

cardiovascular diseasenatural productsneutrophil extracellular trapsthrombosis

Substanzen

Biological ProductsFibrinolytic AgentsPlatelet Aggregation InhibitorsAnticoagulants

Autor:innen und Institutionen

  • Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece.

ORCID-Profile: Despoina Pantazi

Zitieren

APA

Magkoulia, M. N., & Pantazi, D. (2026). Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events. Phytotherapy Research, 40(11), 6130-6153. https://doi.org/10.1002/ptr.70415

Vancouver

Magkoulia MN, Pantazi D. Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events. Phytotherapy Research. 2026;40(11):6130-6153. doi:10.1002/ptr.70415

BibTeX
@article{Magkoulia2026,
  author = {Magkoulia, Maria Nektaria and Pantazi, Despoina},
  title = {Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6130--6153},
  doi = {10.1002/ptr.70415}
}
Kostenlos starten →